Local Anesthetic Injections Safety for People with Hemophilia

Understanding Haemophilia and Local Anaesthesia in Dentistry

Haemophilia is an inherited bleeding disorder caused by a deficiency in specific clotting proteins, most commonly factor VIII in haemophilia A and factor IX in haemophilia B. In healthy individuals, minor vascular microtrauma during everyday activities or medical interventions is rapidly sealed by a stable fibrin mesh. For a person living with a coagulopathy (clotting disorder), the secondary phase of blood clotting is impaired, leading to prolonged, delayed, or recurrent bleeding rather than faster blood loss. When receiving dental care, the method used to achieve pain relief requires precise clinical consideration to prevent inadvertent vascular injury.

Local anaesthesia is essential for restorative, periodontal, endodontic, and surgical dental procedures to eliminate pain and minimise procedural stress. However, delivering local anaesthetic agents involves introducing a fine needle through mucosal surfaces and underlying connective tissues, which are richly supplied with blood vessels. While superficial infiltration into the attached gingiva poses minimal bleeding risk, deeper regional injections carry significant hazards for people with bleeding diatheses. Understanding the relationship between injection depth, tissue anatomy, and clotting capacity is critical for ensuring patient safety during routine and emergency dental visits.

Anatomical Considerations and the Risks of Deep Nerve Blocks

A critical focus in dental care is dental nerve block hemophilia safety, particularly concerning the inferior alveolar nerve block (IANB). The IANB is traditionally used to anaesthetise lower teeth by depositing local anaesthetic near the mandibular foramen within the pterygomandibular space. This anatomical region contains the inferior alveolar neurovascular bundle, the lingual nerve, and a dense network of veins known as the pterygoid venous plexus. When a needle penetrates this loose, non-fibrous connective tissue space, any vascular puncture can lead to uncontained extravasation (leakage) of blood, forming a deep intramuscular haematoma (collection of blood outside blood vessels).

The primary hazard of a deep haematoma in the pterygomandibular, submandibular, or parapharyngeal spaces is potential airway obstruction. Unlike a superficial bruise on the skin or gingiva, a haematoma in deep fascial planes cannot be managed with direct digital pressure. The accumulating blood can track downward and medially, elevating the floor of the mouth and displacing the tongue posteriorly, mirroring the life-threatening airway compromise seen in Ludwig's angina. Because of this anatomical risk, conventional deep block injections are generally avoided in patients with moderate or severe haemophilia unless appropriate clotting factor replacement therapy has been administered beforehand.

Bleeding Risk Stratification in Congenital Coagulopathies

Clinical safety protocols depend heavily on categorising the severity of the patient's haemophilia. The condition is clinically staged according to baseline plasma clotting factor levels: mild (between 5% and 40% of normal activity, or 0.05 to 0.40 IU/mL), moderate (1% to 5%, or 0.01 to 0.05 IU/mL), and severe (less than 1%, or below 0.01 IU/mL). Patients with mild haemophilia usually bleed excessively only after major trauma or surgery, whereas those with severe haemophilia can experience spontaneous internal bleeding into joints and deep muscle spaces.

In addition to baseline factor levels, the presence of factor inhibitors—neutralising alloantibodies directed against infused factor VIII or IX—fundamentally changes risk management. Patients with high-titre inhibitors do not respond to standard factor replacement infusions and require bypassing agents such as activated prothrombin complex concentrates or recombinant activated factor VII. Dentists must verify the patient's exact diagnosis, baseline factor concentration, and current inhibitor status before selecting an anaesthetic method or carrying out any invasive dental intervention.

Pre-Procedural Assessment and Haematology Liaison

Safe dental management for a patient with haemophilia begins with direct multidisciplinary communication between the dental practitioner and the patient's comprehensive haemophilia treatment centre. The dental team must formulate a complete treatment plan detailing the specific teeth involved, the types of local anaesthetic injections anticipated, and whether any soft tissue or bone manipulation will occur. The haematologist then determines the necessity, dosage, and timing of systemic haemostatic cover, ensuring that systemic clotting factor levels are optimised before the needle is introduced.

Depending on the severity of the disorder and whether a nerve block is unavoidable, pre-treatment preparation may involve intravenous factor concentrate infusions to raise circulating factor levels to a safe threshold (frequently target ranges of 30% to 50% for block anaesthesia). For individuals with mild haemophilia A, desmopressin (DDAVP) may be administered via intravenous, subcutaneous, or concentrated intranasal routes to trigger the release of endogenous factor VIII and von Willebrand factor. Additionally, antifibrinolytic agents such as tranexamic acid are commonly prescribed to stabilise fibrin clots and prevent late secondary breakdown.

Alternative Anaesthetic Techniques and Comparative Safety

To maintain dental nerve block hemophilia safety and eliminate the risk of deep fascial haematomas, contemporary dental practice favours alternative, low-risk local anaesthetic techniques. Buccal infiltration involves depositing anaesthetic solution into the loose connective tissue beneath the oral mucosa adjacent to the target tooth. In the maxilla (upper jaw), where the bone is porous, infiltration is universally effective. In the mandible (lower jaw), using 4% articaine with 1:100,000 adrenaline (epinephrine) via buccal infiltration often provides sufficient pulpal anaesthesia for restorative and endodontic treatments without requiring an IANB.

Other highly effective targeted modalities include intraligamentary (periodontal ligament) injections and intraosseous anaesthesia. The intraligamentary technique uses specialized high-pressure syringes to introduce small volumes of anaesthetic directly into the periodontal ligament space, where dense collagen fibres prevent haematoma expansion. Intraosseous anaesthesia delivers solution straight into the cancellous bone through a small cortical perforation. Both techniques provide profound local anaesthesia restricted to single teeth while avoiding major vessels and deep tissue spaces, making them the preferred first-line approaches in haemophilic patients.

Step-by-Step Clinical Protocol During the Dental Visit

On the day of treatment, the clinical team confirms that prescribed systemic factor replacement or antifibrinolytic therapy was taken according to schedule. The patient's baseline vital signs are recorded, and the procedural area is prepared with optimal illumination and suction. If local infiltration or intraligamentary injection is planned, a topical anaesthetic gel (such as 20% benzocaine or 5% lidocaine) is applied to the dried mucosa for two minutes to reduce initial puncture trauma and capillary microbleeding at the surface.

When an injection is administered, the clinician uses a standard aspirating dental syringe equipped with a fine-gauge needle (such as a 27-gauge or 30-gauge). Active aspiration is carried out before and during slow injection to confirm the needle tip has not entered a blood vessel. Formulations containing a vasoconstrictor, such as adrenaline, are typically preferred because localised vasoconstriction reduces regional capillary bleeding and slows anaesthetic systemic clearance. The total volume injected should be the minimum necessary to achieve clinical efficacy, avoiding excessive tissue distension.

Following the injection, direct gentle pressure is applied over the mucosal puncture site with a sterile gauze compress for one to two minutes. The patient is observed in the dental chair for immediate signs of tissue expansion or blanching. Throughout the appointment, the clinical team avoids aggressive retraction of the lips, cheeks, or tongue to prevent mucosal shearing injuries or sublingual haematomas caused by dental mirror pressure.

Post-Treatment Recovery and Normal versus Abnormal Healing

Patients must be clearly instructed on what to expect following dental local anaesthesia. Normal post-procedural recovery involves transient numbness lasting between one and four hours, accompanied by mild, localized tenderness at the needle entry point. Soft tissues may show minimal, pin-point surface bruising, which resolves without intervention over several days. Patients are cautioned against inadvertently chewing or biting their numb lips, tongue, or buccal mucosa, as self-inflicted soft tissue trauma is a frequent cause of severe oral bleeding in children and adults with coagulopathies.

Abnormal healing, in contrast, manifests as progressive or deep-seated pain, noticeable swelling that feels tense or firm on palpation, or continuous oozing from the injection site. Delayed bleeding often occurs between twelve and seventy-two hours post-treatment if a temporary fibrin clot dissolves without sufficient secondary factor support. If the patient notices increasing tightness in the throat, difficulty swallowing (dysphagia), or voice changes, these are critical signs that a haematoma may be spreading into deeper tissue spaces.

Management of Post-Injection Bleeding and Haematoma Formation

If localized bleeding occurs at an accessible mucosal puncture site, immediate local haemostatic measures should be applied. The clinician or patient should place a gauze swab saturated with a 5% tranexamic acid solution directly over the site, maintaining continuous, uninterrupted pressure for at least twenty minutes. Systemic oral tranexamic acid rinses (e.g., 10 mL of a 5% solution rinsed gently for two minutes and spat out, four times daily) can be continued for several days under haematological guidance to maintain local fibrin stability.

In the event of a suspected deep pterygomandibular or parapharyngeal haematoma, the patient requires urgent evaluation. The primary medical intervention is prompt systemic administration of clotting factor concentrates to elevate factor activity, preventing further bleeding expansion. Incision and drainage of a coagulopathy-related haematoma is generally avoided, as surgical cutting through un-clotted, vascular planes usually worsens haemorrhage. If acute airway narrowing occurs due to sublingual or pharyngeal displacement, urgent hospital admission for definitive airway management (such as endotracheal intubation or tracheostomy) by an emergency or maxillofacial surgical team is required.

Preventive Oral Healthcare and Long-Term Maintenance

The primary strategy for ensuring local anaesthetic safety in individuals with bleeding disorders is minimizing the need for invasive dental procedures through rigorous prevention. Maintaining optimal plaque control with twice-daily brushing using a soft-bristled toothbrush and fluoridated toothpaste prevents periodontal disease and dental caries. Interdental cleaning using floss or interdental brushes must be performed with correct technique to prevent repeated mechanical trauma to inflamed gingival tissues.

Dietary and cultural factors play an important role in long-term oral health. Regular consumption of refined carbohydrates, acidic beverages, and chewing substances can accelerate tissue damage. In populations where the use of paan (betel quid), gutka, or chewing tobacco is prevalent, patients face heightened risks of oral submucous fibrosis, chronic gingival inflammation, and mucosal friability, all of which complicate dental anaesthesia and amplify bleeding tendencies. Regular six-monthly dental examinations allow clinicians to detect and treat early lesions using non-invasive or minimal-intervention techniques, eliminating the need for deep anaesthetic blocks.

Evidence and further reading

International clinical authorities, including the World Federation of Hemophilia (WFH) and the British Society for Disability and Oral Health (BSDH), have established clear clinical consensus guidelines for providing dental care to people with inherited bleeding disorders. These bodies emphasize that while local infiltration, intraligamentary, and intraosseous techniques can generally be performed safely with minimal or no systemic factor cover in mild cases, deep nerve blocks—especially inferior alveolar nerve blocks—carry a defined risk of life-threatening airway compromise and necessitate formal haematological consultation and factor replacement therapy.

Peer-reviewed dental literature, including systematic reviews published in the *International Journal of Oral and Maxillofacial Surgery*, the *Journal of the American Dental Association (JADA)*, and *Haemophilia*, reinforces that modern infiltration techniques using 4% articaine offer comparable pulpal anaesthesia in mandibular teeth to traditional nerve blocks, significantly reducing procedural morbidity. Clinicians are advised to consult updated guidelines from the World Federation of Hemophilia and coordinate directly with designated Haemophilia Comprehensive Care Centres for patient-specific protocols.